Home › Insufficienza cardiaca › Texas › Austin
Studi clinici su Insufficienza cardiaca a Austin, TX
18 studi su Insufficienza cardiaca cercano partecipanti presso sedi a Austin e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Alleviant ALLAY-HFrEF Study
In reclutamento
- Austin Heart, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
In reclutamentoFase 3
- Austin Heart, Austin
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
In reclutamentoFase 3
- Research Site, Austin
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
In reclutamentoFase 3
- CON-10015 Austin, TX Investigational Site, Austin
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
In reclutamentoStudio osservazionale
- Texas Cardiac Arrhythmia Research Foundation, Austin
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
In reclutamentoFase 3
- Austin, TX Investigative Site 10015, Austin
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Dell Children's Medical Center of Central Texas, Austin
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
In reclutamentoStudio osservazionale
- Austin, Austin
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
In reclutamentoFase 3
- Tenax Investigational Site, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- Austin Heart, Austin
Alleviant ALLAY-HF Study
In reclutamento
- Austin Heart, Austin
Assessment of CCM in HF With Higher Ejection Fraction
In reclutamento
- Ascension Seton, Austin
- Austin Heart, Austin
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
In reclutamentoFase 3
- FIN-10015 Austin, TX Investigational Site, Austin
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
In reclutamento
- Austin Heart, Austin
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
In reclutamento
- Ascension Texas Cardiovascular, Austin
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Texas Cardiac Arrhythmia Research Foundation, Austin
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
In reclutamento
- The University of Texas Austin, Austin
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
In reclutamentoStudio osservazionale
- Austin Heart, Austin
Studi su Insufficienza cardiaca in altre città
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Atlanta, GA25 studi
- Kansas City, MO25 studi
Altri studi a Austin
- Cancro del polmone non a piccole cellule30 studi
- Cancro (tutti i tipi)20 studi
- Obesità20 studi
- Cancro metastatico19 studi
- Cancro colorettale19 studi
- Cancro al seno18 studi
- Sovrappeso18 studi
- Cancro ovarico17 studi
- Cancro dell'endometrio15 studi
- Cancro alla prostata15 studi
- Depressione14 studi
- Cancro al seno triplo negativo13 studi
Fonte: ClinicalTrials.gov, dati recuperati il 4 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.